RICT 2017

Drug Discovery & Selection

53rd International Conference on Medicinal Chemistry
53èmes Rencontres Internationales de Chimie Thérapeutique

 July 5-7, 2017    Toulouse, Occitanie (formerly Languedoc Roussillon Midi-Pyrénées), France

Programme


08:00

Registration & Welcome Coffee

09:30

RICT 2017 Opening

Michel BALTAS
CNRS, UNIVERSITY OF TOULOUSE, Toulouse, France
Armand LATTES
UNIVERSITE PAUL SABATIER, Toulouse, France
Alexis VALENTIN
UNIVERSITÉ PAUL SABATIER, Toulouse, France
Luc VAN HIJFTE
SCT & NOVITHERA, Nijmegen, The Netherlands

Session 1: Paul Ehrlich Award Lecture
Sponsored by Janssen Research & Development

Session Chairs

Jean-François BONFANTI
JANSSEN R&D, Val de Reuil, France
Luc VAN HIJFTE
SCT & NOVITHERA, Nijmegen, The Netherlands

10:00

PL01 - Sugars & Proteins: Glycomimetics to Target Infectious Disease

Benjamin DAVIS
OXFORD UNIVERSITY, Oxford, United Kingdom

11:00

Coffee break & Exhibition

Session 2: Peptides & Sugars in Drug Discovery

Session Chair

Olivier LAVERGNE
, Palaiseau, France

11:30

PL02 - Peptide Drugs to Target GPCR- State of the Art and Innovative Application

Annette BECK-SICKINGER
LEIPZIG UNIVERSITY, Leipzig, Germany

12:15

Lunch break & Exhibition

13:00

Poster Session 1 (odd numbers) & Exhibition

Session 3: Recent Advances in Immuno-oncology
Sponsored by Evotec

Session Chair

Gilbert LASSALLE
EVOTEC, Toulouse, France

14:30

PL03 - Small Molecule Approaches in Immune Modulation in Cancer.

Ronan O'HAGAN
MERCK, SHARP & DOHME, Boston, United States

15:15

PL04 - Immunotherapy of Cancers: The Lessons of Oncodermatology; Melanoma as a Model

Nicolas MEYER
ONCOPOLE TOULOUSE, Toulouse, France

16:00

Coffee break & Exhibition

16:30

PL05 - Novel Small Molecule MerTK Inhibitors and their Biological Uses

Xiaodong WANG
UNIVERSITY OF NORTH CAROLINA, Chapel Hill, United States

17:15

PL06 - Discovery of PF-06840003, a Novel IDO Inhibitor for Cancer Immunotherapy

Stefano CROSIGNANI
ITEOS THERAPEUTICS SA, Gosselies, Belgium

18:00

Welcome & Networking Reception

19:30

End of Day 1

Session 4: Inspired by Nature

Session Chair

Michel BALTAS
CNRS, UNIVERSITY OF TOULOUSE, Toulouse, France

08:30

PL07 - De Novo Drug Design — Inspiration from Nature

Gisbert SCHNEIDER
ETH ZÜRICH, Zürich, Switzerland

09:15

Start of sessions

Session 4: Inspired by Nature
Session 5: Advances in Kinase Inhibitors Discovery
Session 4: Inspired by Nature
Session Chair
Michel BALTAS
CNRS, UNIVERSITY OF TOULOUSE, Toulouse, France
Session 5: Advances in Kinase Inhibitors Discovery
Session Chair
Jean-Yves ORTHOLAND
EDELRIS, Lyon, France
10:15

Coffee break & Exhibition

10:45

Start of sessions

Session 6: Accessing Novel Chemical Space
Session 7: Structure Based Design
Session 6: Accessing Novel Chemical Space
Session Chair
Janos SAPI
SCT & UNIVERSITY OF REIMS-CHAMPAGNE-ARDENNE, Reims, France
Session 7: Structure Based Design
Session Chair
Jean-Paul RENAUD
RIBOSTRUCT, Ostwald, France
12:15

Lunch break & Exhibition

13:00

Poster Session 2 (even numbers) & Exhibition

13:45

Career Session

14:30

Start of sessions

Session 8: New Tools for Therapeutic Innovation
Session 9: Advances in Proteases Inhibitor Discovery
Session 8: New Tools for Therapeutic Innovation
Session Chair
YVES GENISSON
UNIVERSITE PAUL SABATIER - LSPCMIB, Toulouse, France
Session 9: Advances in Proteases Inhibitor Discovery
Session Chair
Patrick JIMONET
SANOFI, Vitry sur Seine, France
15:30

Start of sessions

Session 10: Rare Diseases
Session 11: Neglected Diseases
Session 10: Rare Diseases
Session Chair
YVES GENISSON
UNIVERSITE PAUL SABATIER - LSPCMIB, Toulouse, France
Session 11: Neglected Diseases
Session Chair
Patrick JIMONET
SANOFI, Vitry sur Seine, France
16:15

Coffee break & Exhibition

17:30

Start of sessions

Session 12: Synthetic Biology
Session 13: Tackling PPIs
Session 12: Synthetic Biology
Session Chair
Sebastien PAPOT
SCT & UNIVERSITY OF POITIERS, Poitiers, France
Session 13: Tackling PPIs
Session Chair
Andras KOTSCHY
SERVIER RESEARCH INSTITUTE OF MEDICINAL CHEMISTRY, Budapest, Hungary
18:15

End of Day 2

19:00

Cocktail at the City Hall

20:30

Gala Dinner

Session 14: Advances in Kinase Inhibitors Discovery & Development
Sponsored by Galapagos

Session Chair

Romain GOSMINI
GALAPAGOS, Romainville, France

08:30

PL18 - Development of Dual IGF1R/INSR Inhibitors - A Case Study

Heather TYE
EVOTEC LTD, Abingdon, United Kingdom

09:15

PL19 - Identifying High Quality, Potent and Selective Inhibitors of ATM Kinase for Oncology Therapies: Discovery of AZD0156

Bernard BARLAAM
ASTRAZENECA, Cambridge, United Kingdom

10:00

Coffee break & Exhibition

10:30

PL20 - Raising the Gold Standard: Design & Development of Highly Selective JAK3 Probes (Janus Kinase 3)

Stefan LAUFER
UNIVERSITY OF TÜBINGEN, Tübingen, Germany

11:15

PL21 - Leniolisib (CDZ173) - Discovery of a New Generation of Potent and Selective PI3Kδ Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases

Nicolas SOLDERMANN
NOVARTIS, Basel, Switzerland

Session 15: Pierre Fabre Award Lecture
Sponsored by Institut de Recherche Pierre Fabre

Session Chair

Michel PEREZ
PIERRE FABRE, Toulouse, France

12:00

PL22 - Creating, Varying and Selecting : The Driving Forces in Drug Discovery and Chemical Biology Pierre Fabre Award lecture

Benoit DEPREZ
UNIVERSITY OF LILLE 2, Lille, France

13:00

RICT 2017 Closing remarks & Prizes (Reaxys Award, Poster Prizes)

Sebastien PAPOT
SCT & UNIVERSITY OF POITIERS, Poitiers, France

13:15

Introduction to RICT 2018

Dominique BONNET
CNRS-UNIVERSITY OF STRASBOURG, Illkirch, France

13:30

End of symposium

14:45

Optional visit of the Airbus Facilities